Initiate

Don't miss our value and access experts discussing "Valuing Value: Defining Pharmaceutical Value in 2024" at this Life Science Access Academy live-streamed masterclass on 10th September 2024. Jonathan Gibson Jane Moorhouse Adelaide Shaw-Maguire #masterclass #marketaccess #HTA #value

The Initiate team are excited to announce that eight of our research poster abstracts have been accepted for presentation at ISPOR EU 2024! These posters cover a diverse range of topics, from analysis of reimbursement outcomes in the Orphan drug space (across Europe and a focus on Ireland and Germany) to discussions around the Joint HTA process and traditional launch sequencing. Some disease-specific research includes carer burden modelling in Spinal Muscular Atrophy, and the cost-effectiveness of immunotherapies for advanced or recurrent endometrial cancer. A big thank you to our incredible team for their hard work and commitment to demonstrating their knowledge and expertise in reimbursement, market access and health economics. We look forward to discussing our research with you in Barcelona! #ISPOREU2024 #HealthEconomics #OutcomesResearch #Teamwork #Research #Posters

Rounding up Initiate's Reimbursement Radar series for Q1 & Q2 2024, @Georgia Roberts reports on the reimbursement decisions made in obstetrics and gynaecology. Keep an eye out for our Q3 Reimbursement Radar posts in October! If you would like to know more do get in touch and follow Initiate for more insights on reimbursement decisions across different disease areas. #ReimbursementRadar #HTA #HEOR #MarketAccess #Obstetrics #Gynaecology

Blood Cancer Awareness Month 2024 September is Blood Cancer Awareness Month, a time to shine a light on the challenges faced by those affected by blood cancers such as leukaemia, lymphoma, and myeloma. Blood cancers account for around 10% of all cancer diagnoses in the UK, impacting thousands of lives each year. This month, let’s come together to raise awareness, support research, and advocate for better treatments and care. How can you help? Educate yourself and others: Learn about the different types of blood cancers and share this knowledge with your network. Support research: Consider donating to organisations dedicated to blood cancer research and patient support. Be a lifeline: Register as a blood or bone marrow donor. Your donation could save a life. Share stories: If you or someone you know has been affected by blood cancer, share your story to inspire and inform others. Together, we can make a difference. Let’s stand in solidarity with those battling blood cancer and work towards a future where these diseases are a thing of the past. #SayBloodCancer #BloodCancerAwarenessMonth #SupportResearch #SaveLives #BloodCancerUK https://lnkd.in/eSq4JXMs

In the next instalment of Initiate's Reimbursement Radar, Tom Edmonds reports on the reimbursement decisions made for respiratory diseases in Q1 and Q2 2024. If you would like to know more do get in touch and follow Initiate for more insights on reimbursement decisions across different disease areas. #ReimbursementRadar #HTA #HEOR #MarketAccess #Respiratory

In the latest edition of Initiate's Thought Leadership series, Joanne Mumford and Harry Lewis consider the latest meeting of the HTA Stakeholder Forum and its implications for the JCA process in Europe. Click below to read👇 #marketaccess #thoughtleadership #HTA #jointHTA

We are thrilled to announce our attendance at the ESMO 2024 Congress in Barcelona! This prestigious event brings together the brightest minds in oncology to share ground-breaking research, innovative treatments, and the latest advancements in cancer care. Our team is eager to engage with fellow professionals, exchange ideas, and explore new collaborations. We look forward to contributing to the discussions and learning from the incredible lineup of speakers and sessions. Stay tuned for updates and insights from the congress! Contact Adelaide Shaw-Maguire to arrange a conference meetup to discuss how we can help you achieve successful reimbursement for your oncology products. #ESMO24 #Oncology #Cancer #marketaccess #healtheconomics #conference #reimbursement

Don't miss Andrew Mumford in this live-streamed masterclass on Celtic Nations NHS Update :

Continuing Initiate's Reimbursement Radar series, Charlotte A. reports on the reimbursement decisions made in gastroenterology and hepatology in Q1 and Q2 2024. If you would like to know more do get in touch and follow Initiate for more insights on reimbursement decisions across different disease areas. #ReimbursementRadar #HTA #HEOR #MarketAccess #Gastroenterology #Hepatology

Introducing 5 silver sponsors attending the World Orphan Drug Congress! 💫 This year's event is a great opportunity to network with them on the exhibition floor. 🏢Initiate, Marken, Mendelian, OMAKASE CONSULTING and Pharma BP Don't miss the chance to meet companies changing the orphan drug landscape! Register now from €495 ➡️ https://buff.ly/3t7msim 🗓️ Pre-Congress Workshops | 22 October 2024 | Catalonia Barcelona Plaza 🗓️ Main Congress | 23-25 October 2024 | Fira de Barcelona Montjuic #WODC #OrphanDrugs #RareDisease #OrphanDrugAdvocate #PatientAdvocacy